Sebastian Palmqvist

Dr. Gregg Day, a specialist in Alzheimer's diagnostics, and Dr. Sebastian Palmqvist, an expert on cognitive conditions, delve into groundbreaking advancements in blood testing for Alzheimer's. They discuss a revolutionary blood test that boasts a 90% diagnostic accuracy and a staggering positive predictive value of 95 to 99% for patients with cognitive symptoms. This innovative approach is set to transform how Alzheimer's disease is diagnosed, offering a more precise alternative to traditional methods.

Dr. Gregg Day, a specialist in Alzheimer's diagnostics, interviews Dr. Sebastian Palmqvist, a leading researcher in blood biomarker studies for Alzheimer's. They discuss the evolution of Alzheimer’s diagnosis, highlighting the shift to blood tests for streamlined and cost-effective evaluations. The conversation covers the accuracy of these biomarkers and the challenges of integrating them into clinical practice. The duo also addresses interpreting intermediate test results and the importance of establishing trust among healthcare professionals in these innovative diagnostic tools.

Sebastian Palmqvist, MD, PhD, and Wiesje van der Flier, PhD, are cochairs of the 2024 Alzheimer’s Association International Conference, while Rita Rubin serves as Lead Senior Staff Writer for JAMA Medical News. They delve into exciting topics like a groundbreaking blood test for Alzheimer’s, the repurposing of GLP-1 receptor agonists, and potential risks from inhaling wildfire smoke. They also discuss the importance of blood-based biomarkers and advancements in Alzheimer’s diagnosis and treatment, emphasizing the need for responsible implementation in clinical settings.